Julian A. Symons

Julian A. Symons is the EVP and Chief Scientific Officer at Aligos Therapeutics. Julian has also worked as a Research Scientist at F. Hoffmann-La Roche, Senior Director of Product Development at Alios BioPharma, and Vice President of Disease Area Research & Development Leader for Respiratory Infections at Alios BioPharma, Inc., a Janssen Pharmaceutical Company of Johnson and Johnson. Dr. Symons was educated at the University of Sheffield and the University of Edinburgh, where they earned their Ph.D. in organic chemistry.

Julian A. Symons received a D.Phil. in Immunology and Autoimmunity from the University of York. Julian also holds a B.Sc. (Hons) in Biochemistry and Physiology from the University of Central Lancashire.

Some of their coworkers include Lesley Ann Calhoun - EVP, CFO, Leonid Beigelman - President and Director, and John Fry - EVP, Clinical Development. Julian A. Symons reports to Lawrence M. Blatt, Chief Executive Officer and Director.